Department of Pediatrics.
Institute for Clinical and Translational Research.
Fam Syst Health. 2021 Jun;39(2):234-247. doi: 10.1037/fsh0000507. Epub 2021 Apr 26.
Despite the significant impact of type 1 diabetes (T1D) on family, few instruments are available to assess health-related quality of life (HRQOL) among family members of people with T1D. This study aimed to develop and evaluate the psychometric properties of new measures of diabetes-specific HRQOL for parents and partners of people with T1D. We report on the multistep development and validation process for the self-report Type 1 Diabetes and Life (T1DAL) measures, with versions for parents of youth age <8, 8-11, 12-17, and 18-25 years, and for partners of people age ≥18 years with T1D.
First, we conducted qualitative interviews (total parents/partners n = 38) to develop draft measures and piloted them (total n = 20). Next, we tested the measures' psychometric properties. Participants (total across versions n = 813) at six T1D Exchange Clinic Network sites completed the appropriate T1DAL measure and validated measures of related constructs. We then reduced each T1DAL measure to 20-30 items in length based on psychometric data and participant feedback. Eleven participants reviewed the final measures via cognitive debriefing.
The T1DAL measures for parents and partners demonstrated good internal consistency (α = .80-.88) and test-retest reliability (r = .73-.86). Correlations with measures of general quality of life, generic and diabetes-specific HRQOL, and diabetes burden demonstrated construct validity. Factor analyses identified 3-4 subscales/measure. Participants reported being satisfied with the shortened measures, which took 5-10 minutes to complete.
The new T1DAL measures for parents and partners of people with T1D are reliable, valid, and ready for use in research and clinical settings. (PsycInfo Database Record (c) 2021 APA, all rights reserved).
尽管 1 型糖尿病(T1D)对家庭有重大影响,但评估 T1D 患者家庭成员健康相关生活质量(HRQOL)的工具却很少。本研究旨在开发和评估针对 T1D 患者父母和伴侣的新糖尿病特异性 HRQOL 测量工具的心理测量特性。我们报告了多步骤的自我报告 1 型糖尿病和生活(T1DAL)测量工具的开发和验证过程,其中包括年龄<8、8-11、12-17 和 18-25 岁的青少年父母以及年龄≥18 岁的 T1D 患者伴侣的版本。
首先,我们进行了定性访谈(父母/伴侣共 38 人),以开发草案措施并对其进行试点(共 20 人)。接下来,我们测试了这些措施的心理测量特性。六个 T1D 交换诊所网络地点的参与者(各版本共 813 人)完成了适当的 T1DAL 措施和相关构念的验证措施。然后,我们根据心理测量数据和参与者反馈将每个 T1DAL 措施缩短至 20-30 个项目。11 名参与者通过认知性汇报审查了最终措施。
父母和伴侣的 T1DAL 措施表现出良好的内部一致性(α=.80-.88)和重测信度(r=.73-.86)。与一般生活质量、通用和糖尿病特异性 HRQOL 以及糖尿病负担的措施的相关性表明了其结构有效性。因子分析确定了 3-4 个分量表/措施。参与者报告说,他们对缩短后的措施感到满意,这些措施需要 5-10 分钟才能完成。
针对 T1D 患者父母和伴侣的新型 T1DAL 措施具有可靠性和有效性,可用于研究和临床环境。